(1)
Eichenfeld, L.; Siegfried, E.; Kwong, P. .; Cutler, S. .; Willson, C.; Rumney, P.; Crosby, C.; Andres, J.; McBride, M. Proportion of Subjects Achieving a Molluscum Lesion Count of or 1 at the Day 84 End of Study Visit in Phase 3 Clinical Trials With VP-102 CAMP-1 and CAMP-2. J of Skin 2021, 5, s92.